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Abstract
We used cultured adult mouse retinae as a model system to follow and quantify the retraction of dendrites using diolistic labelling
of retinal ganglion cells (RGCs) following explantation. Cell death was monitored in parallel by nuclear staining as ‘labelling’ with
RGC and apoptotic markers was inconsistent and exceedingly difficult to quantify reliably. Nuclear staining allowed us to delineate
a lengthy time window during which dendrite retraction can be monitored in the absence of RGC death. The addition of brain-
derived neurotrophic factor (BDNF) produced a marked reduction in dendritic degeneration, even when application was delayed
for 3 days after retinal explantation. These results suggest that the delayed addition of trophic factors may be functionally benefi-
cial before the loss of cell bodies in the course of conditions such as glaucoma.
Introduction
The adult murine retina provides an attractive model to study detailed
structural alterations of neurons following axotomy (Johnson & Mar-
tin, 2008; Bull et al., 2011; Guerin et al., 2011; Wood et al., 2011;
Denk et al., 2015; White et al., 2015). While the loss of retinal gan-
glion cells (RGCs) has typically been used as the primary read-out in
this preparation (Bull et al., 2011), fewer studies address the changes
that might occur in the dendrites of axotomized RGCs prior to cell
loss (see Discussion for a very recent example, Johnson et al., 2016).
Yet dendritic atrophy following axotomy may be of considerable
functional relevance while also offering a therapeutic opportunity in
conditions such as glaucoma (Weber et al., 1998; Morgan, 2012;
El-Danaf & Huberman, 2015). In principle, dendritic arbourization
can be readily quantiﬁed by analytical tools, such as Sholl analysis
(Sholl, 1953), in which proximal dendrite loss is reﬂected by a low-
ered peak amplitude and reduced terminal branching density is indi-
cated by a leftward shift in the proﬁle. Sholl analysis has been further
developed with the introduction of the notion of a ‘branching index’
(Garcia-Segura & Perez-Marquez, 2014). While Sholl analysis is as
such well-established and used extensively to quantify dendritic
arbourization in numerous central nervous system (CNS) structures,
the procedures allowing unbiased and sparse labelling of individual
cells are less straightforward. In particular, the RGC morphology
varies greatly between cell types in the rodent eye, reﬂecting the
large number of individual cell types (Sun et al., 2002; Coombs
et al., 2006). In view of this, random labelling of RGCs would be
desirable to minimize bias. Sparse labelling using transgenic animals
is frequently used to analyse dendritic arbours in the CNS including
those of RGCs, typically using the Thy1 promoter coupled to geneti-
cally encoded ﬂuorescent reporters. While elegant and convenient,
this approach is not without problems given observations by us and
others that the Thy1 promoter may be up or downregulated following
axotomy (Lee et al., 1998; Schlamp et al., 2001; Huang et al., 2006;
Astafurov et al., 2014). As the mechanisms underlying sparse expres-
sion of the Thy1 promoter in transgenic animals are still unknown, it
is also unclear whether RGC labelling is truly random or not. In this
study, we use an acute labelling technique designated diolistics (Gan
et al., 2000) to determine the time course of neuronal dendritic atro-
phy following RGC axotomy. The use of this technique revealed that
dendritic alterations occur within hours following axotomy and pre-
cede by days the loss of RGCs, thus allowing us to explore the effect
of brain-derived neurotrophic factor (BDNF) on dendrites days before
any confounding effects caused by the rescue of RGC cell bodies.
This is potentially a signiﬁcant confounding factor as BDNF has been
known for a long time to prevent the death of RGCs in a number of
species, both in vitro and in vivo after axotomy (Rodriguez-Tebar
et al., 1989; Meyer-Franke et al., 1995; Di Polo et al., 1998).
Materials and methods
Explant preparation and culture
Seventy-eight adult C57/Bl6 mice aged 1.5–8.5 months of either sex
were killed by cervical dislocation in accordance with United
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Kingdom Home Ofﬁce regulations. Eyes were immediately enucle-
ated into ice-cold Hanks balanced Salt Solution (Invitrogen Ltd.,
Paisley, UK), and the retinas rapidly dissected onto 0.4 lm polyte-
traﬂuoroethylene culture inserts (Millipore, Watford, UK), ganglion
cell layer (GCL) facing up. Inserts were placed into 35 mm culture
dishes (Millipore) containing 1.2 mL Neurobasal-A culture medium
(Invitrogen Ltd.) supplemented with 1% penicillin-streptomycin
(Invitrogen Ltd.), 0.8 mM L-glutamine (Invitrogen Ltd.), 1% N2
supplement (Invitrogen Ltd.) and 2% B27 supplement (Invitrogen
Ltd.). Explants were cultured at 37 °C, 5% CO2 for up to 14 days.
For culture periods exceeding 1 day, the medium was replaced daily
to prevent accumulation of toxins.
Nuclear staining
At the end of the culture period 18 explants (n = 15 mice of both
sex, aged 2–7 months) were ﬁxed (4% paraformaldehyde, 4 h), cry-
oprotected (30% sucrose, overnight) and frozen in optimal cutting
temperature compound. Sagittal sections (10–14 lm) were cut using
a cryostat (Leica CM 3050S), nuclear stained (TO-PRO-3, 10 min)
and coverslipped with Prolong Gold anti-fade reagent (Invitrogen
Ltd.). Sections were imaged at 209 by confocal microscopy (Zeiss,
LSM 510, release version 4.2 SP1) (633 nm laser with 651–704 nm
detector). Z-stacked 1024 9 1024 pixel images were obtained in
1 lm steps and the central 1 lm slice analysed.
Immunohistochemistry
At the end of the culture period 16 retinas (n = 14 mice of both
sex, aged 2–7 months) were ﬁxed and cryosectioned (v.s.). Sections
were labelled with the RGC markers NeuN, TUJ1 and Thy1.2, and
the apoptotic marker active caspase-3. Antibody working concentra-
tions and sources are given in Table 1. Incubations were at room
temperature, unless stated otherwise. Sections were blocked with 5%
chicken serum (Invitrogen Ltd., 30 min), then incubated with pri-
mary antibody (4 h or overnight at 4 °C). Sections were incubated
with secondary antibody (1.5 h), nuclear stained with TO-PRO-3
(10 min), and coverslipped with Prolong Gold anti-fade reagent.
Positive controls were anterior sections of sagittally cut mouse brain
(NeuN, TUJ1 and Thy1.2) or mouse spleen sections (active caspase-
3). Negative controls were as follows: primary antibody only, sec-
ondary antibody only, no antibody. Sections were imaged at 209 by
confocal microscopy using separate channels for the ﬂuorophore
(488 nm argon laser with 500–530 nm bandpass ﬁlter) and nuclear
stain (633 nm laser). Z-stacked 1024 9 1024 pixel images were
obtained in 1 lm steps. The central 1 lm slice was analysed. NeuN-
and TUJ1-positive cells in the GCL were double stained for nuclear
stain and antibody. Mean green channel intensity was calculated
with the image processing software FIJI (Schindelin et al., 2012) as
the [mean green channel count for the layer]  [mean green channel
count for background outside the region of interest].
Viability assay
The terminal deoxynucleotidyl transferase dUTP nick-end labelling
(TUNEL) assay (Millipore, UK Ltd.) was used according to the
manufacturer’s protocol to quantify apoptosis in retinas cultured for
up to 14 days. Brieﬂy, frozen sections of 14 explants (n = 13 mice
of both sex, aged 2–7 months) were digested with proteinase-K
before labelling with TdT end-labelling cocktail, and then Avidin-
FITC. Sections were counterstained with TO-PRO-3, and cover-
slipped with Prolong Gold Anti-fade reagent. Positive controls were
retinal sections pre-incubated in proteinase-K for 1 h. Negative con-
trols were prepared by omission of Avidin-FITC. Sections were
imaged at 209 by confocal microscopy using separate channels for
Avidin-FITC (488 nm argon laser with 500–530 nm bandpass ﬁlter)
and TO-PRO-3 (633 nm laser). Z-stacked 1024 9 1024 pixel
images were obtained and analysed as previously described. Mean
green channel intensity was calculated as before.
Diolistics and Sholl analysis
Fifty explants (n = 38 mice of both sex, aged 1.5–5 months) were
cultured for up to 3 days. Tungsten particles (200 mg) were coated
with 3 mg 1-1-dioctadecyl-3,3,3,3-tetramethylindocarbocyanine per-
chlorate (DiI) and 6 mg 3,3-dioctadecyloxacarbocyanine perchlorate
(DiO), and distributed along Tefzel tubing (Bio-rad, Hertfordshire,
UK) using a Tubing Prep Station (Bio-rad). The tubing was cut into
1.2 cm ‘bullets’ (Gan et al., 2000). At the end of the culture period,
DiI/DiO-coated tungsten particles were ﬁred using a Helios gene
gun (Bio-rad) 5 cm from the retinal surface at 120 psi (helium)
through a 3 lm polyethylene terephthalate membrane ﬁlter (Scien-
tiﬁc Laboratory Supplies Ltd., Yorkshire, UK) to prevent clumping
of dye particles. Explants were then incubated at 37 °C, 5% CO2
for 30 min, followed by ﬁxation with 4% paraformaldehyde
(10 min), and nuclear stained with TO-PRO-3 (10 min). Finally,
Table 1. Antibodies and stains used for immunohistochemistry
Primary antibodies
Speciﬁcity Cells labelled Source (isotype) Clone Company Working concentration
NeuN Neurons Mouse (IgG2a) Monoclonal Abcam 5 lg/mL
TUJ1 Neurons Mouse (IgG2a) Monoclonal Covance 5 lg/mL
Thy1.2 RGCs Rat (IgG2b) Monoclonal Abcam 2.5 lg/mL
Active caspase-3 Apoptotic cells Rabbit Polyclonal Chemicon (Millipore) 10 lg/mL
Secondary antibodies and nuclear stain
Speciﬁcity Conjugate Source Company Working concentration
Mouse IgG AlexaFluor 488 Goat Invitrogen – Molecular Probes Inc. 4 lg/mL
Rat IgG AlexaFluor 488 Goat Abcam 4 lg/mL
Rabbit IgG AlexaFluor 488 Goat Invitrogen – Molecular Probes Inc. 4 lg/mL
TO-PRO-3 iodide 642 Invitrogen – Molecular Probes Inc. 1 lM
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explants were coverslipped with Prolong Gold anti-fade reagent and
imaged within 24 h.
Diolistically labelled RGCs were identiﬁed as having a soma in the
GCL and an axon projecting to the optic nerve. RGCs were imaged at
209 by confocal microscopy using separate channels for each dye
(DiI 543 nm laser with 565–615 nm bandpass ﬁlter; DiO 488 nm
argon laser with 500–530 nm bandpass ﬁlter). Z-stacked 512 9 512
or 1024 9 1024 8-bit pixel images of the entire cell were obtained in
1 lm steps. Cell eccentricities relative to the optic nerve head were
noted using the Stage Controller Stepper (Zeiss). RGC images were
imported into FIJI and dendritic arbours traced in 3D. Dendritic
integrity was quantiﬁed by 3D Sholl analysis using the Simple Neurite
Tracer plugin (Longair et al., 2011) centred on the soma centre with a
sphere interval of 10 lm. The area under the Sholl proﬁle was calcu-
lated using the trapezoidal model. The branching index was calculated
as described by Garcia-Segura and Perez-Marquez using the number
of dendrite intersections, I, at each radial distance from the soma cen-
tre, x (Garcia-Segura & Perez-Marquez, 2014). Brieﬂy, at each radial
distance > 0 lm the number of new dendrites was multiplied by the
radial distance. The sum equated to the branching index for that cell.




½Ix  ðIxnÞ  x
where xi = 10 lm; xmax = 300 lm; n = 10 lm; [Ix  (Ix  n)] > 0.
BDNF treatment
To test a possible role of BDNF in delaying RGC dendropathy, the
medium was supplemented with 100 ng/mL E. coli recombinant
BDNF (Regeneron/Amgen) diluted in 19 PBS containing 0.1%
bovine serum albumin (BSA). Ten explants (n = 10 mice of both sex,
aged 2–5.5 months) were cultured in BDNF-supplemented medium
for 3 days initiated at 0 day. Controls had medium with the same vol-
ume aliquot (2 lL/1 mL medium) of vehicle. As before, the medium
was replaced daily, along with fresh BDNF (100 ng/mL) or vehicle.
At the end of the culture period RGCs were diolistically labelled and
analysed by Sholl analysis. Dendritic ﬁeld area was calculated as the
area enclosed by a linear polygon connecting the terminal dendrites.
All cells were masked prior to analysis.
Pan-caspase inhibition
To assess the role of caspase activation in RGC dendritic retraction,
the pan-caspase inhibitor, Q-VD (R&D Systems, Abingdon, UK),
was applied to nine explants (n = 6 mice, female, aged 3–4 months).
Q-VD has been shown to be one of the most effective broad-spec-
trum caspase inhibitors and at 100 lM Q-VD is non-toxic and highly
effective at preventing apoptosis in mouse lymphoblast cells (Caserta
et al., 2003) and 52.6 lM Q-VD protects against RGC death in the
rat retina (Patil & Sharma, 2004). A topical aliquot (100 lL) of
100 lM Q-VD, or vehicle (DMSO) as control, was applied daily.
After 2 days retinas were labelled (diolistics) and nuclear stained
(TO-PRO-3). Sholl proﬁles were derived for labelled cells as
described. Cell analysis was undertaken in a masked fashion.
Delayed BDNF treatment
To test the neuroprotective role of BDNF in a more clinically rele-
vant setting, six explants (n = 6 mice, male, aged 8.5 months) were
cultured in BDNF-free medium for 3 days, followed by culture in
BDNF-supplemented medium (100 ng/mL BDNF) for a further
3 days (6 days total). Fresh BDNF was added with each daily
medium change. Controls had vehicle only. RGCs were labelled
diolistically and analysed in a masked fashion as before.
Cell sub-type analysis
To account for cell-subtype bias, cells were classiﬁed as ON, OFF and
bistratiﬁed according to dendritic termination within the inner plexi-
form layer (IPL); cells with dendrites terminating within the ﬁrst 3/5
(~ 9 lm) of the IPL were categorized as ON, those with dendrites ter-
minating in the end 2/5 (~ 6 lm) of the IPL were categorized as OFF.
Bistratiﬁed cells had dendrites terminating in both sublaminae.
Statistical analysis
Data processing was carried out using MICROSOFT EXCEL (Ofﬁce
2013). Statistical analysis was carried out using IBM SPSS (version
20). Normality of data was tested using the Shapiro–Wilk test. To
compare two groups independent samples t-test, pairwise one-way
ANOVA or pairwise Kruskal–Wallis one-way ANOVA was used. Com-
parison between multiple groups was made by one-way ANOVA with
TUKEY post hoc, or Mann–Whitney with Bonferroni correction.
P < 0.05 was the level of signiﬁcance. Mean values are
given  SEM. The regression model for factors inﬂuencing the
Sholl proﬁle included culture period/culture conditions, age and sex
(1 = male, 2 = female) as explanatory variables.
Results
Our ﬁrst objective was to determine the time window during which
dendrite extension can be studied before the death of axotomized
RGCs sets in. The number of cells in the GCL, quantiﬁed by
nuclear staining (Fig. 1A), was not found to decrease signiﬁcantly
during the ﬁrst week following explantation but then did so by
2 weeks by 37.5% (P = 0.001, ANOVA with Tukey post hoc). The
INL thickness decreased by 24.5% by 3 days (P = 3.293 9 1011,
ANOVA with Tukey post hoc), to a maximum of 35.6% by 7 days
(P = 3.815 9 1013). The ONL thickness decreased by 16.4% after
3 days (P = 1.18 9 104, Mann–Whitney tests with Bonferroni cor-
rection), to a maximum of 25.3% after 14 days (P = 1.38 9 1011,
Fig. 1B). We next examined the expression of neuronal markers
using antibodies to NeuN (Fig. 2A), TUJ1 (Fig. 2B) and Thy1.2
(Fig. 2C). During the same 2 week period the number of NeuN-
positive cells decreased by 83.5% (P = 1.256 9 106, ANOVA with
Tukey post hoc, Fig. 2D), whereas the number of TUJ1-positive
cells decreased by 68.6% (P = 3.408 9 105, ANOVA with Tukey
post hoc, Fig. 2E). In contrast, Thy1.2 staining increased 3.5-fold
after 3 days (P = 0.002, ANOVA with Tukey post hoc), and remained
elevated thereafter (Fig. 2F). Next, cell death was examined by
active caspase-3 (Fig. 3A) or TUNEL staining (Fig. 3B). Active
caspase-3 staining was minimal in all layers at all time points,
except in the ONL, where we measured a 4.4-fold increase by
14 days (P = 0.006, Mann–Whitney tests with Bonferroni correc-
tion, Fig. 3C–F). TUNEL staining was minimal in all layers at
0 day. Staining peaked at 3 days in the GCL (4.0-fold increase,
P = 2.41 9 104, Mann–Whitney tests with Bonferroni correction),
and at 7 days in the INL (3.5-fold increase, P = 6.93 9 103) and
ONL (24.5-fold increase, P = 2.82 9 1070), see Fig. 3G–I.
Having established that no signiﬁcant signs of cell death is
observed in the GCL during the ﬁrst week of culture, RGCs were
labelled diolistically for morphometric analysis (Fig. 4A–C). Sur-
prisingly, dendritic shrinkage, measured as a decrease in Sholl area
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under the curve (AUC), could be observed as early as after 6 h
post-mortem (P = 4.91 9 102, Mann–Whitney tests with Bonfer-
roni correction, Fig. 4A–C), which further progressed over the next
3 days (P = 2.42 9 109, Fig. 4D and E). The branching index
reduced by 41.9  6.0% by 1 day (P = 0.007, ANOVA with Tukey
post hoc), after which it remained relatively unchanged (Fig. 4F).
Having deﬁned a window of several days during which alterations
in the dendritic proﬁle could be analysed in the absence of cell
death, the Sholl proﬁles were also determined separately for ON,
OFF, bistratiﬁed RGC sub-types. No bias could be detected at any
of the time points examined. Thus, compared with the same cell
type at time 0, the Sholl AUC of ON cells decreased by
49.0  7.1% (P = 4.02 9 104, Mann–Whitney tests with Bonfer-
roni correction) after 2 days and by 61.0  5.6%
(P = 2.50 9 105) after 3 days. The corresponding values for the
OFF cells decreased by 37.9  6.5% (P = 1.91 9 103) after
1 days and by 30.1  17.0% (P = 4.96 9 102) after 2 days and
for the bistratiﬁed cells 48.0  8.1% (P = 4.83 9 102) after
2 days (see also Fig. 4G). To examine any potential role of con-
founding variables, a multiple regression analysis was run with Sholl
AUC as the dependent variable and culture period, age and sex as
predictors. The model provided a good ﬁt for the data
(P = 7.27 9 1012, ANOVA) with the time of culture period as the
only signiﬁcant predictor (B =  228, P = 7.08 9 1010) of Sholl
AUC.
Having established that our culture conditions and labelling tech-
nique allow us to analyse the role of BDNF in modulating dendritic
atrophy following axotomy without the confounding factor of RGC
loss or of biases towards particular RGC populations, we next
supplemented the culture medium for a period of 3 days with BDNF
added at 0 or 3 days (see Fig. 5A for a summary of the procedure,
with representative cells illustrated in Fig. 5B and C). Following
incubation with BDNF, the Sholl proﬁle increased at 20–80 lm
from the soma centre (P < 0.05, Kruskal–Wallis), relative to con-
trols (Fig. 5D). The Sholl AUC increased by 75.8  14.8%
(P = 0.002, ANOVA with Tukey post hoc) relative to controls and
was not signiﬁcantly different to that measured at 0 day (Fig. 5E).
The addition of BDNF increased branching by 81.0  15.7%
(P = 1.94 9 104, ANOVA with Tukey post hoc), relative to controls
and was not signiﬁcantly different compared to 0 day cells
(Fig. 5F). The dendritic ﬁeld area of BDNF-treated cells was
61.2  13.9% (P = 0.011, ANOVA with Tukey post hoc) larger com-
pared with controls and 28.8  6.1% (P = 0.004) smaller than that
of 0 day cells (Fig. 5G and H). We next examined possible sub-
type-speciﬁc effects of BDNF and analysed ON, OFF and ON-OFF
RGCs based on IPL stratiﬁcation depth. The Sholl AUC of BDNF-
treated ON cells increased by 108.9  22.4% (P = 0.003, ANOVA
with Tukey post hoc) relative to controls, not signiﬁcantly different
from 0 day cells. BDNF-treated OFF cells increased by
73.6  30.2% (P = 0.047) relative to controls, with no signiﬁcant
difference from 0 day cells, as was also the case for bistratiﬁed cells
(Fig. 5I). The possible confounding effects of age and sex were
tested by multiple regression analysis. Area under the Sholl proﬁle
was the dependent variable and culture condition (1 = control and
2 = BDNF-treated), age and sex were predictors. The model pro-
vided a good ﬁt of the data (P = 0.022, ANOVA) and in this case, the
culture condition, plus or minus BDNF, was found to be the only
signiﬁcant predictor (B = 665, P = 0.008) of Sholl AUC.
Fig. 1. Nuclear stained frozen sections of explants cultured for up to 14 d. (A) Representative 8-bit images of TO-PRO-3 labelled sections; scale bars 100 lm.
(B) Linear cell counts of GCL show cell loss after 14 d. **P < 0.005, ns, not signiﬁcant, ANOVA with Tukey post hoc. (C) INL thickness measured after each
culture period show layer thinning after 3 d. ***P < 0.001, ANOVA with Tukey post hoc. (D) ONL thickness measured after each culture period show layer thin-
ning after 3 d. ***P < 0.001, Mann–Whitney with Bonferroni correction. n = 5 retinas, 3 animals (0 d), n = 6 retinas, 5 animals (3 d), n = 3 retinas, 3 animals
(7 d), n = 4 retinas, 4 animals (14 d). At least three sections from each retina were analysed. Error bars  SEM. d, days.
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Fig. 2. Immunoﬂuorescence shows maintenance of neuronal markers over 14 d culture of retinal explants. (A) Staining for neuronal marker NeuN (green) coun-
ter-stained with TO-PRO-3 nuclear stain (blue) in frozen sections of explants cultured for up to 14 d. n = 3 retinas, 3 animals (0 d), n = 3 retinas, 3 animals
(3 d), n = 3 retinas, 3 animals (7 d), n = 3 retinas, 3 animals (14 d). (B) Staining for neuronal marker TUJ1 (green) counter-stained with TO-PRO-3 nuclear stain
(blue) in frozen sections of explants cultured for up to 14 d. n = 3 retinas, 3 animals (0 d), n = 3 retinas, 3 animals (3 d), n = 3 retinas, 3 animals (7 d), n = 3
retinas, 3 animals (14 d). (C) Staining for RGC marker Thy1.2 (green) counter-stained with TO-PRO-3 nuclear stain (blue) in frozen sections of explants cultured
for up to 14 d. n = 3 retinas, 2 animals (0 d), n = 3 retinas, 3 animals (3 d), n = 3 retinas, 3 animals (7 d), n = 5 retinas, 5 animals (14 d). (D) Quantiﬁcation of
NeuN-positive cells in the GCL, shown with nuclear stained-only cells for comparison. ***P < 0.001, ANOVA with Tukey post hoc. (E) Quantiﬁcation of TUJ1-
positive cells in the GCL, shown with nuclear stained-only cells for comparison. ***P < 0.001, ANOVA with Tukey post hoc. (F) Thy1.2 staining in each retinal
layer quantiﬁed as mean green channel intensity, normalized for background ﬂuorescence, as described in the text. **P < 0.005, ***P < 0.001, ANOVA with Tukey
post hoc. Positive controls: brain. Scale bars: 100 lm. At least three sections from each retina were analysed. Error bars  SEM. d, days.
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We next determined the extent to which dendritic degeneration
could be mitigated by caspase inhibition within 2 days of culture
(Fig. 6A–C), a time interval selected as this presented the peak
for the change in dendrite conﬁguration. Indeed, recent results
suggest that the degeneration of neuronal processes may involve
mechanisms requiring caspase activity (Williams et al., 2006;
Nikolaev et al., 2009; D’Amelio et al., 2010; Hyman & Yuan,
2012; Erturk et al., 2014). While the Sholl proﬁle was greater at
10–30 lm compared with untreated controls (P < 0.05, Kruskal–
Wallis, Fig. 6D), the Sholl AUC, branching index and dendritic
Fig. 3. Fluorescent staining of apoptotic markers, active caspase-3 and TUNEL in frozen sections of explants cultured for up to 14 d. (A) Active caspase-3
staining (green) with TO-PRO-3 nuclear stain (blue) over 14 d at 209 magniﬁcation (top) and higher magniﬁcation of areas highlighted with dashed boxes to
show individual cells (bottom). Active caspase-3 staining tended to increase with time. Arrows indicate active caspase-3 positive cells. Positive control: spleen.
Scale bars: 100 lm (top), 10 lm (bottom). n = 5 retinas, 3 animals (0 d); n = 3 retinas, 3 animals (3 d); n = 3 retinas, 3 animals (7 d); n = 5 retinas, 5 animals
(14 d). (B) TUNEL labelling (green) with TO-PRO-3 nuclear stain (blue) over 14 d at 209 magniﬁcation (top) and higher magniﬁcation of areas highlighted
with dashed boxes to show individual cells (bottom). TUNEL labelling increased over time. Arrows indicate TUNEL-positive cells. Positive control: proteinase-
k-digested retinal sections. Scale bars: 100 lm (top), 10 lm (bottom). n = 4 retinas, 3 animals (0 d); n = 4 retinas, 4 animals (3 d); n = 3 retinas, 3 animals
(7 d); n = 3 retinas, 3 animals (14 d). (C) Number of active caspase-3-positive cells in GCL quantiﬁed per mm. P > 0.05, Mann–Whitney with Bonferroni cor-
rection. (D) Number of active caspase-3-positive cells in GCL quantiﬁed as % of cells in GCL. P > 0.05, Mann–Whitney with Bonferroni correction. (E) Num-
ber of active caspase-3-positive cells in INL quantiﬁed per mm. P > 0.05, Mann–Whitney with Bonferroni correction. (F) Number of active caspase-3-positive
cells in ONL quantiﬁed per mm. *P < 0.05, Mann–Whitney with Bonferroni correction. (G) TUNEL staining in GCL quantiﬁed as mean green channel ﬂuores-
cence, normalized for background ﬂuorescence. ***P < 0.001, Mann–Whitney with Bonferroni correction. (H) TUNEL staining in INL quantiﬁed as mean
green channel ﬂuorescence, normalized for background ﬂuorescence. *P < 0.05, **P < 0.005, Mann–Whitney with Bonferroni correction. (I) TUNEL staining
in ONL quantiﬁed as mean green channel ﬂuorescence, normalized for background ﬂuorescence. *P < 0.05, ***P < 0.001, Mann–Whitney with Bonferroni
correction. At least three sections from each retina were analysed. Error bars  SEM. d, days.
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ﬁeld area while showing a similar trend, did not reach signiﬁ-
cance (Fig. 6E–G). Given this trend and the possibility of cell
selectivity in the effect of Q-VD, RGC sub-type-speciﬁcity was
also examined with ON, OFF and ON-OFF separately examined.
However, this analysis did not reveal any evidence of a differen-
tial protective effect of pan-caspase inhibitors. Age was also
checked as a possible confounder by multiple regression analysis
but again the only variable found to be a predictor of Sholl AUC
was the presence or absence of Q-VD in the culture medium
(B = 464, P = 0.005).
Given the potential clinical relevance of the ﬁnding that BDNF
retards the progression of dendritic atrophy, we next examined
whether its delayed addition would also be effective, given the clear
progression of dendritic retraction following axotomy in the absence
of RGC death (see Fig. 7A–C). The corresponding Sholl proﬁle was
greater at 20–100 lm (P < 0.05, Kruskal–Wallis) compared with
Fig. 4. Diolistically labelled RGCs from explants cultured for up to 3 d show dendrite loss over time. (A) Representative 512 9 512 pixel (0 d) or
1024 9 1024 pixel (rest) images of RGCs at each time point; scale bars 100 lm; arrow indicates axon. (B) Locations of all labelled RGCs plotted relative to
the optic nerve head (origin). (C) Diagram of prepared explant with optic nerve head indicated. D, dorsal; T, temporal; scale bar 1 mm. (D) Sholl plots for
RGCs at each time point. (E) Area under Sholl proﬁles at each time point. *P < 0.05, ***P < 0.001, Mann–Whitney with Bonferroni correction. (F) Branching
index of RGCs. **P < 0.005, ***P < 0.001, ANOVA with Tukey post hoc. (G) Sholl AUC for each culture period split by RGC sub-type. ON (left): n = 28 cells
(0 d), n = 14 cells (6 h), n = 13 cells (1 d), n = 26 cells (2 d), n = 28 cells (3 d). OFF (middle): n = 12 cells (0 d), n = 4 cells (6 h), n = 8 cells (1 d), n = 8
cells (2 d), n = 5 cells (3 d). ON-OFF (right): n = 11 cells (0 d), n = 6 cells (6 h), n = 11 cells (1 d), n = 7 cells (2 d), n = 4 cells (3 d). *P < 0.05,
**P < 0.005, ***P < 0.001, Mann–Whitney with Bonferroni correction. The numbers of cells analysed (D) are indicated. Error bars  SEM. d, days.
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untreated controls (Fig. 7D). Sholl AUC increased by
135.6  29.6% (P = 1.08 9 104, ANOVA with Tukey post hoc) rel-
ative to controls and 56.6  19.7% (P = 0.003) relative to 3 days,
but decreased by 32.2  8.5% (P = 0.009) relative to 0 day
(Fig. 7E). The branching index for delayed BDNF-treated cells was
increased by 106.8  29.2% (P = 0.009, ANOVA with Tukey post
Fig. 5. Diolistically labelled RGCs from explants cultured with 100 ng/mL BDNF, or vehicle (PBS, 0.1% BSA) as control, over 3 d showing retardation of
dendritic atrophy in the presence of BDNF. (A) Time course of experiment. (B) Representative 1024 9 1024 pixel images of RGCs from control (top) and
BDNF (bottom) with 8-bit tracing images for each cell (right); scale bars 100 lm; arrow indicates axon. (C) Locations of RGCs from control (top) and BDNF-
treated (bottom) explants plotted relative to the optic nerve head (origin). (D) Sholl proﬁles for RGCs in each group. *P < 0.05, **P < 0.005, ***P < 0.001,
Kruskal–Wallis. (E) Area under Sholl proﬁles in each group, shown with the 0 d value for comparison. **P < 0.005, ***P < 0.001, ns, not signiﬁcant, ANOVA
with Tukey post hoc. (F) Branching index. ***P < 0.001, ns, not signiﬁcant, ANOVA with Tukey post hoc. (G) Dendritic ﬁeld area of RGCs, shown with the
0 d value for comparison. *P < 0.05, **P < 0.005, ***P < 0.001, ANOVA with Tukey post hoc. (H) Example of dendritic ﬁeld area measurement using 8-bit
tracing. Scale bar 100 lm, arrow indicates axon (not included in measurement). (I) Sholl AUCs split according to RGC stratiﬁcation depth. ON (left): n = 28
cells (0 d), n = 8 cells (control), n = 26 cells (BDNF). OFF (middle): n = 20 cells (0 d), n = 7 cells (control), n = 10 cells (BDNF). ON-OFF (right): n = 13
cells (0 d), n = 3 cells (control), n = 3 cells (BDNF). *P < 0.05, **P < 0.005, ***P < 0.001, ANOVA with Tukey post hoc. The number of cells analysed (D)
are indicated. Error bars  SEM. d, days.
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Fig. 6. Diolistically labelled RGCs from explants cultured with 100 lM pan-caspase inhibitor, Q-VD, or vehicle (DMSO) as control over 2 d showing modest
protective effect of Q-VD on dendritic atrophy of RGCs. (A) Time course of experiment. (B) 1024 9 1024 pixel images of ﬂuorescently labelled RGCs from
control (top) and Q-VD-treated (bottom) explants with 8-bit tracing images for each cell (right). Scale bars 100 lm. Arrow indicates axon. (C) Locations of
every labelled RGC from control (top) and Q-VD-treated (bottom) explants plotted relative to the optic nerve head (origin). (D) Sholl proﬁles of labelled RGCs.
*P < 0.05, ANOVA. (E) Area under Sholl proﬁles shown with the value for 0 d for comparison. ***P < 0.001, ANOVA with Tukey post hoc. (F) Branching index
of RGCs. ***P < 0.001, ANOVA with Tukey post hoc. (G) Dendritic ﬁeld area of RGCs in each group shown with the value for 0 d as comparison.
***P < 0.001, ANOVA with Tukey post hoc. (H) Sholl AUCs split by RGC sub-type. ON (left): n = 28 cells (0 d), n = 2 cells (control), n = 10 cells (Q-VD).
OFF (middle): n = 12 cells (0 d), n = 9 cells (control), n = 13 cells (Q-VD). ON-OFF (right): n = 11 cells (0 d), n = 0 cells (control), n = 1 cell (Q-VD).
*P < 0.05, **P < 0.005, ***P < 0.001, ANOVA with Tukey post hoc. The numbers of cells analysed (D) are indicated. Error bars  SEM. d, days.
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hoc), compared to controls, but decreased by 45.1  7.7% relative
to 0 day (P = 0.002), relative to 0 day (Fig. 7F). The dendritic ﬁeld
area was 133.9  32.8% increased (P = 1.93 9 105, ANOVA with
Tukey post hoc), compared with untreated controls, but was
43.1  8.0% decreased (P = 4.59 9 105), compared to 0 day
(Fig. 7G). To check for sub-type-speciﬁc effects of delayed BDNF
Fig. 7. Diolistically labelled RGCs from explants cultured with 100 ng/mL BDNF or vehicle (PBS, 0.1% BSA) as control over 3 d from day 3 showing that
delayed BDNF treatment is capable of retarding dendritic retraction of RGCs. (A) Time course of experiment. (B) Representative 1024 9 1024 pixel images of
RGCs from control (top) and delayed BDNF-treated (bottom) explants with 8-bit tracing images for each cell (right); scale bars 100 lm; arrow indicates axon. (C)
Locations of RGCs from control (top) and delayed BDNF-treated (bottom) explants plotted relative to the optic nerve head (origin). (D) Sholl proﬁles for RGCs.
*P < 0.05, **P < 0.005, ***P < 0.001, Kruskal–Wallis. (E) Area under Sholl proﬁles in each group, shown with the values for 0 and 3 d for comparison.
*P < 0.05, **P < 0.005, ***P < 0.001, ns, not signiﬁcant, ANOVA with Tukey post hoc. (F) Branching index of RGCs. *P < 0.05, **P < 0.005, ***P < 0.001,
ns, not signiﬁcant, ANOVA with Tukey post hoc. (G) Dendritic ﬁeld area of RGCs shown with value for 0 d as comparison. **P < 0.005, ANOVA with Tukey post
hoc. (H) Sholl AUCs split according to RGC sub-type. ON (left): n = 28 cells (0 d), n = 12 cells (control), n = 14 cells (delayed BDNF). OFF (middle): n = 12
cells (0 d), n = 2 cells (control), n = 6 cells (delayed BDNF). ON-OFF (right): n = 11 cells (0 d), n = 0 cells (control), n = 2 cells (delayed BDNF). *P < 0.05,
**P < 0.005, ***P < 0.001, ns, not signiﬁcant, ANOVA with Tukey post hoc. The number of cells analysed (D) are indicated. Error bars  SEM. d, days.
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treatment, ON, OFF and ON-OFF cells were also examined sepa-
rately. The Sholl AUC for ON cells was increased by
95.8  30.4% (P = 0.020, ANOVA with Tukey post hoc) relative to
untreated cells and increased by 55.2  24.1% (P = 0.025) relative
to 3 days cells, and 39.5  9.4% decreased (P = 0.033), compared
with 0 day cells. The Sholl AUC for OFF cells was increased by
253.3  80.2% (P = 0.001) compared with untreated cells, though
this was not signiﬁcantly different compared with 0 and 3 days
cells. The Sholl AUC of bistratiﬁed cells was not signiﬁcantly dif-
ferent between groups (Fig. 7H). There was no signiﬁcant difference
for BDNF-treated cells between sub-types, indicating an absence of
sub-type-speciﬁc effects of BDNF. Regression analysis conﬁrmed
culture condition (1 = control, 2 = delayed BDNF-treated) as the
only factor inﬂuencing dendritic integrity (B = 671, P = 0.001).
Discussion
The key novel ﬁnding here is that delayed application of BDNF sig-
niﬁcantly retards dendritic atrophy of RGCs following retinal
explantation. While this manuscript was being revised, a related
study was published using mouse retinal explants and time-series
imaging of Thy1-YFP-labelled RGCs (Johnson et al., 2016). This
study showed that the joint addition of ciliary neurotrophic factor
and BDNF at the time of explantation attenuates dendritic loss over
the effects of forskolin alone, thus broadly supporting our conclu-
sions (see below for further discussion).
To ensure that under our experimental conditions, the loss of den-
drites can be studied in the absence of RGC death, we ﬁrst estab-
lished the time course of cell loss in the GCL. We found that the
pattern of cell loss identiﬁed by the RGC markers NeuN, Tuj1 and
Thy1.2 was inconsistent, likely reﬂecting the lack of truly speciﬁc
markers (Perry et al., 1984; Gan et al., 1996). In addition, the
expression of proteins, including Thy1 (Lee et al., 1998; Schlamp
et al., 2001; Huang et al., 2006; Astafurov et al., 2014), may alter
following injury, as we report here (Fig. 2). Therefore, we con-
cluded that the use of nuclear staining to quantify RGC loss is more
reliable, given that amacrine cells are resistant to degeneration (Kun-
zevitzky et al., 2010) and that the numbers of apoptotic cells in the
GCL detected by TUNEL and active caspase-3 were negligible over
14 days. Using nuclear staining, we found that RGC counts do not
decrease signiﬁcantly during the course of the ﬁrst week (Fig. 1B).
As the loss of RGC dendrites can already be observed 6 h after
explantation (Fig. 4D), a substantial time window exists during
which the protective effects of BDNF can be studied, even under
conditions of delayed addition (Figs 5 and 7). A detailed analysis of
the process of dendritic retraction (Fig. 4D) revealed an initial left-
ward shift of the (Sholl) proﬁle, possibly resulting from selective
loss of distal dendrites, as reported in axotomized mouse RGCs
(Morquette et al., 2015). In contrast, we can discount sub-type bias
after ﬁnding no signiﬁcant differences in Sholl AUC between ON,
OFF or bistratiﬁed cells at any time point, and the absence of sam-
pling bias as a function of eccentricity (Fig. 4B). A key difference
between our study and the results published by Johnson et al.,
2016 lies in the method used to assess dendritic arbourization.
While we randomly labelled cells by diolistics at different time
points, Johnson et al. use a Thy-1 YFP line that also sparsely
labelled RGCs, with the advantage that individual cells can be fol-
lowed over time. However, in addition to the persistent unresolved
question of the mechanisms leading to single-cell marking that may
or may not select for subclasses of neurons in the CNS, we previ-
ously noted that genetically encoded reporters such as YFP can
underreport dendritic pathology (Williams et al., 2013), possibly
because probes are more likely to be expressed in cells less affected
by the lesion, with a biosynthetic machinery that is still intact. In
contrast, diolistics labelling relies on temperature-dependent diffu-
sion within the plasma membrane, regardless of the health of the
cell. This may explain why in the very recent study by Johnson
and colleagues, dendritic pathology was not reported before 7 days
of culture, a time point at which the death of RGCs was already
signiﬁcant (Johnson et al., 2016). This temporal coincidence makes
it difﬁcult to separate cell death from dendritic atrophy and while
we have no explanation as to why under our experimental condi-
tions, no signiﬁcant RGC death (determined by nuclear staining)
can be observed during the ﬁrst week following explantation, we
think that our much earlier detection of dendritic atrophy may be
explained by a combination of the use of an unbiased labelling
method (Sherazee & Alvarez, 2013) coupled with the underreport-
ing dendritic pruning when using Thy1-YFP animals (Williams
et al., 2013).
As such, the effects of BDNF on dendrites may not be too sur-
prising given previous reports by others in various areas of the
CNS, typically during development (McAllister et al., 1995, 1996;
Bosco & Linden, 1999; Horch et al., 1999; Lom & Cohen-Cory,
1999; Jin et al., 2003; Baquet et al., 2004; Rauskolb et al., 2010).
Of special relevance are previous experiments indicating that BDNF
treatment reduces dendritic retraction of RGCs in vivo in a cat optic
nerve crush model (Weber & Harman, 2008) and an optic nerve
transection model (Rodger et al., 2012).
In conclusion, we show that application of BDNF alone attenuates
dendritic retraction of randomly labelled RGCs in the adult retinal
explant. Crucially, this BDNF protective effect can also be observed
following delayed application of BDNF, a signiﬁcant new observa-
tion that may have important implications for the treatment of neu-
rodegenerative disorders, such as glaucoma.
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